Bio-Rad Laboratories (BIO) Gross Profit (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Gross Profit for 18 consecutive years, with $345.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Profit changed 0.14% year-over-year to $345.8 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 0.4% change from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 2.83% from the prior year.
• Gross Profit was $345.8 million for Q2 2026 at Bio-Rad Laboratories, up from $309.4 million in the prior quarter.
• Over five years, Gross Profit peaked at $402.6 million in Q1 2022 and troughed at $306.0 million in Q1 2025.
• A 5-year average of $353.8 million and a median of $350.4 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit declined 14.64% in 2022 and gained 6.02% in 2024, its largest moves.
• Over 5 years, Gross Profit stood at $397.1 million in 2022, then dropped by 7.76% to $366.3 million in 2023, then fell by 6.63% to $342.0 million in 2024, then gained by 0.94% to $345.2 million in 2025, then gained by 0.17% to $345.8 million in 2026.
• The last three Gross Profit figures came in at $345.8 million (Q2 2026), $309.4 million (Q1 2026), and $345.2 million (Q4 2025), per Business Quant data.